Rani Therapeutics Holdings, Inc. financial data

Symbol
RANI on Nasdaq
Location
2051 Ringwood Avenue, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 269 % -81.2%
Debt-to-equity 562 % +339%
Return On Equity -220 % -237%
Return On Assets -56.7 % -42.5%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 54.1M USD -57.8%
Weighted Average Number of Shares Outstanding, Basic 28.8M shares +12.9%
Weighted Average Number of Shares Outstanding, Diluted 28.8M shares +12.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 27.5M USD -35.2%
General and Administrative Expense 24.3M USD -12.4%
Operating Income (Loss) -51.8M USD +26.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.9M USD -7.28%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -28.2M USD +21%
Earnings Per Share, Basic -1.06 USD/shares +67.6%
Earnings Per Share, Diluted -1.06 USD/shares +67.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.28M USD -14%
Marketable Securities, Current 98.5M USD
Assets, Current 32.4M USD -48.8%
Property, Plant and Equipment, Net 5.5M USD -12.1%
Operating Lease, Right-of-Use Asset 5.43M USD +466%
Other Assets, Noncurrent 246K USD
Assets 43.5M USD -38.2%
Accounts Payable, Current 1.57M USD +11.5%
Accrued Liabilities, Current 2.3M USD +60.1%
Liabilities, Current 20.2M USD +175%
Operating Lease, Liability, Noncurrent 4.02M USD +2249%
Liabilities 37.8M USD +6.03%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8K USD
Retained Earnings (Accumulated Deficit) -94M USD -42.8%
Stockholders' Equity Attributable to Parent 3.12M USD -82.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.78M USD -83.4%
Liabilities and Equity 43.5M USD -38.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.4M USD +22.6%
Net Cash Provided by (Used in) Financing Activities 121K USD +1413%
Net Cash Provided by (Used in) Investing Activities 10.3M USD +150%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.01M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.78M USD -12.7%
Deferred Tax Assets, Valuation Allowance 61M USD +15.5%
Deferred Tax Assets, Gross 61M USD +15.5%
Operating Lease, Liability 5.43M USD +466%
Depreciation 111K USD -18.4%
Payments to Acquire Property, Plant, and Equipment 18K USD -92.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28.1M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid 6.66M USD +558%
Property, Plant and Equipment, Gross 5.87M USD +31.3%
Operating Lease, Liability, Current 1.41M USD +78.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.9M USD +623%
Lessee, Operating Lease, Liability, to be Paid, Year One 465K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.24M USD +2230%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.23M USD +64.1%
Deferred Tax Assets, Operating Loss Carryforwards 13M USD +90.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 489K USD +132%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.28M USD
Operating Lease, Payments 180K USD -30.5%
Additional Paid in Capital 97.1M USD +16.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 18.9M USD +0.53%
Share-based Payment Arrangement, Expense 15.8M USD -30.2%
Interest Expense 5.2M USD +15.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%